Table 2.

Serum EPO levels in mice treated with 10 μg of pOr/EPO and 0.5 μg of pMCK/rtTAnls

	Days postinjection
	0	10	30	40	70
Group 1	<5	75 ± 69	48 ± 42	<5	<5
Group 2	<5	<5	<5	34 ± 26	23 ± 4
Control	<5	<5	<5	<5	<5

Group 1 mice were treated with DOX from day 0 to day 30; Group 2, from day 30 to day 70. Control mice were treated with DOX from day 0 to day 70. Values given are serum EPO levels in milliunits/ml.